Metabolomics-Based Blood Test Could Enable Earlier Detection of Cancer
Dr. James Larkin discusses the benefits of biofluid metabolomics and how an NMR-based approach could help to improve the way that cancer is detected and monitored in patients with nonspecific symptoms.